| |
Latest 10 SEC filings (by transaction date) for BHC within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 1/24 | Mar 29/24 | Paulson John | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 5,890 | $10.61 |
Apr 1/24 | Mar 29/24 | Icahn Brett | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 3,122 | $10.61 |
Apr 1/24 | Mar 29/24 | Robertson Russel C | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 2,945 | $10.61 |
Apr 1/24 | Mar 29/24 | Wechsler Amy B | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 647 | $10.61 |
Mar 4/24 | Mar 4/24 | Carson Seana | Direct Ownership | Common Shares, No Par Value | S - Open market or private sale | -133 | $9.80 |
Mar 4/24 | Mar 4/24 | Carson Seana | Direct Ownership | Common Shares, No Par Value | S - Open market or private sale | -1,561 | $9.80 |
Mar 4/24 | Mar 4/24 | Carson Seana | Direct Ownership | Common Shares, No Par Value | S - Open market or private sale | -199 | $9.80 |
Mar 4/24 | Mar 4/24 | Carson Seana | Direct Ownership | Common Shares, No Par Value | S - Open market or private sale | -4,420 | $9.80 |
Mar 4/24 | Mar 1/24 | Barresi John S | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,188 | $9.89 |
Mar 4/24 | Mar 1/24 | Appio Thomas | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -87,803 | $9.89 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for BHC within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 1/24 | Mar 29/24 | Paulson John | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 5,890 | $10.61 |
Apr 1/24 | Mar 29/24 | Icahn Brett | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 3,122 | $10.61 |
Apr 1/24 | Mar 29/24 | Robertson Russel C | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 2,945 | $10.61 |
Apr 1/24 | Mar 29/24 | Wechsler Amy B | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 647 | $10.61 |
Mar 4/24 | Mar 1/24 | Barresi John S | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,188 | $9.89 |
Mar 4/24 | Feb 29/24 | Barresi John S | Direct Ownership | Common Shares, No Par Value | A - Grant, award or other under Rule 16b-3(d) | 39,126 | |
Mar 4/24 | Mar 1/24 | Appio Thomas | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -87,803 | $9.89 |
Mar 4/24 | Mar 1/24 | Appio Thomas | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -23,871 | $9.89 |
Mar 4/24 | Mar 1/24 | Appio Thomas | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,413 | $9.89 |
Mar 4/24 | Mar 1/24 | Appio Thomas | Direct Ownership | Common Shares, No Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,895 | $9.89 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |